Myriad Genetics Files 8-K on Financials

Ticker: MYGN · Form: 8-K · Filed: May 6, 2025 · CIK: 899923

Myriad Genetics Inc 8-K Filing Summary
FieldDetail
CompanyMyriad Genetics Inc (MYGN)
Form Type8-K
Filed DateMay 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

Related Tickers: MYGN

TL;DR

MYGN filed an 8-K today detailing financial results.

AI Summary

Myriad Genetics, Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 322 North 2200 West, Salt Lake City, Utah.

Why It Matters

This 8-K filing provides an update on Myriad Genetics' financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate material adverse events.

Key Players & Entities

  • MYRIAD GENETICS, INC. (company) — Registrant
  • May 6, 2025 (date) — Date of earliest event reported
  • 322 North 2200 West, Salt Lake City, Utah 84116 (address) — Principal executive offices
  • 0-26642 (company_id) — Commission File Number
  • 87-0494517 (company_id) — IRS Employer Identification No.

FAQ

What specific financial information is being reported in this 8-K?

The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was this 8-K report filed?

The report was filed on May 6, 2025.

What is the principal business address of Myriad Genetics, Inc.?

The principal executive offices are located at 322 North 2200 West, Salt Lake City, Utah 84116.

What is the Commission File Number for Myriad Genetics, Inc.?

The Commission File Number is 0-26642.

What is the IRS Employer Identification Number for Myriad Genetics, Inc.?

The IRS Employer Identification Number is 87-0494517.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding MYRIAD GENETICS INC (MYGN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.